Kazia Therapeutics (KZIA) Shares Issued (2012 - 2017)

Kazia Therapeutics' (KZIA) quarterly Shares Issued came in at $113204.0 in Q4 2017, up 849.6% on a QoQ basis from $11921.3 in Q2 2013.

Kazia Therapeutics (KZIA) Shares Issued (2012 - 2017) Analysis & Trends

Kazia Therapeutics (KZIA) has 3 years of Shares Issued data on file, last reported at $113204.0 in Q4 2017.

Quarterly Shares Issued changed N/A year-over-year to $113204.0 in Q4 2017, while the trailing twelve-month figure through Dec 2017 was $113204.0 (changed N/A YoY) and the FY2013 annual result came in at $12326.9, down 55.77% from the prior year.
Shares Issued climbed to $113204.0 in Q4 2017, from $11921.3 in the prior quarter.
In the past five years, Shares Issued ranged from a high of $113204.0 in Q4 2017 to a low of $11921.3 in Q2 2013.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Shares Issued (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	-
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	18.36 Mn
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	-
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	-
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	-
10	Kazia Therapeutics	4.22 Bn	4.22 Bn	-	-

Download Data